Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)

Gespeichert in:

Autor*in:	V. T. Ivashkin [verfasserIn] I. G. Bakulin [verfasserIn] P. O. Bogomolov [verfasserIn] M. V. Matsiyevich [verfasserIn] N. I. Geyvandova [verfasserIn] P. V. Koroy [verfasserIn] S. V. Nedogoda [verfasserIn] O. A. Sablin [verfasserIn] L. G. Lenskaya [verfasserIn] Ye. V. Beloborodova [verfasserIn] A. A. Bagretsova [verfasserIn] R. A. Abdulkhakov [verfasserIn] M. F. Osipenko [verfasserIn] I. V. Osipova [verfasserIn] D. A. Pocheptsov [verfasserIn] Ye. V. Chumachek [verfasserIn] O. M. Khromtsova [verfasserIn] Ye. V. Kuzmicheva [verfasserIn]

Format:	E-Artikel
Sprache:	Russisch

Erschienen:	2018

Schlagwörter:	фосфоглив гепатопротектор неалкогольная жировая болезнь печени воспаление фиброз качество жизни

Übergeordnetes Werk:	In: Российский журнал гастроэнтерологии, гепатологии, колопроктологии - Gastro LLC, 2020, 27(2018), 2, Seite 34-43
Übergeordnetes Werk:	volume:27 ; year:2018 ; number:2 ; pages:34-43

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc Journal toc

DOI / URN:	10.22416/1382-4376-2017-27-2-34-43

Katalog-ID:	DOAJ026246554

Internformat


LEADER	01000caa a22002652 4500
001	DOAJ026246554
003	DE-627
005	20240414034717.0
007	cr uuu---uuuuu
008	230226s2018 xx \|\|\|\|\|o 00\| \|\|rus c
024	7		\|a 10.22416/1382-4376-2017-27-2-34-43 \|2 doi
035			\|a (DE-627)DOAJ026246554
035			\|a (DE-599)DOAJ4131ff0071c74aa1ac7482e20794c338
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a rus
050		0	\|a RC799-869
100	0		\|a V. T. Ivashkin \|e verfasserin \|4 aut
245	1	0	\|a Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)
264		1	\|c 2018
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
650		4	\|a фосфоглив
650		4	\|a гепатопротектор
650		4	\|a неалкогольная жировая болезнь печени
650		4	\|a воспаление
650		4	\|a фиброз
650		4	\|a качество жизни
653		0	\|a Diseases of the digestive system. Gastroenterology
700	0		\|a I. G. Bakulin \|e verfasserin \|4 aut
700	0		\|a P. O. Bogomolov \|e verfasserin \|4 aut
700	0		\|a M. V. Matsiyevich \|e verfasserin \|4 aut
700	0		\|a N. I. Geyvandova \|e verfasserin \|4 aut
700	0		\|a P. V. Koroy \|e verfasserin \|4 aut
700	0		\|a S. V. Nedogoda \|e verfasserin \|4 aut
700	0		\|a O. A. Sablin \|e verfasserin \|4 aut
700	0		\|a L. G. Lenskaya \|e verfasserin \|4 aut
700	0		\|a Ye. V. Beloborodova \|e verfasserin \|4 aut
700	0		\|a A. A. Bagretsova \|e verfasserin \|4 aut
700	0		\|a R. A. Abdulkhakov \|e verfasserin \|4 aut
700	0		\|a M. F. Osipenko \|e verfasserin \|4 aut
700	0		\|a I. V. Osipova \|e verfasserin \|4 aut
700	0		\|a D. A. Pocheptsov \|e verfasserin \|4 aut
700	0		\|a Ye. V. Chumachek \|e verfasserin \|4 aut
700	0		\|a O. M. Khromtsova \|e verfasserin \|4 aut
700	0		\|a Ye. V. Kuzmicheva \|e verfasserin \|4 aut
773	0	8	\|i In \|t Российский журнал гастроэнтерологии, гепатологии, колопроктологии \|d Gastro LLC, 2020 \|g 27(2018), 2, Seite 34-43 \|w (DE-627)1698164203 \|x 26586673 \|7 nnns
773	1	8	\|g volume:27 \|g year:2018 \|g number:2 \|g pages:34-43
856	4	0	\|u https://doi.org/10.22416/1382-4376-2017-27-2-34-43 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/4131ff0071c74aa1ac7482e20794c338 \|z kostenfrei
856	4	0	\|u https://www.gastro-j.ru/jour/article/view/133 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/1382-4376 \|y Journal toc \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2658-6673 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 27 \|j 2018 \|e 2 \|h 34-43

Indexfelder

author_variant	v t i vti i g b igb p o b pob m v m mvm n i g nig p v k pvk s v n svn o a s oas l g l lgl y v b yvb a a b aab r a a raa m f o mfo i v o ivo d a p dap y v c yvc o m k omk y v k yvk
matchkey_str	article:26586673:2018----::fiaynsftogyyriiaicmietesnilhshlpdpopolvtoachlcatlvriesrslsfutcnedulbidadmzdlcbcnr
hierarchy_sort_str	2018
callnumber-subject-code	RC
publishDate	2018
allfields	10.22416/1382-4376-2017-27-2-34-43 doi (DE-627)DOAJ026246554 (DE-599)DOAJ4131ff0071c74aa1ac7482e20794c338 DE-627 ger DE-627 rakwb rus RC799-869 V. T. Ivashkin verfasserin aut Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12) 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier фосфоглив гепатопротектор неалкогольная жировая болезнь печени воспаление фиброз качество жизни Diseases of the digestive system. Gastroenterology I. G. Bakulin verfasserin aut P. O. Bogomolov verfasserin aut M. V. Matsiyevich verfasserin aut N. I. Geyvandova verfasserin aut P. V. Koroy verfasserin aut S. V. Nedogoda verfasserin aut O. A. Sablin verfasserin aut L. G. Lenskaya verfasserin aut Ye. V. Beloborodova verfasserin aut A. A. Bagretsova verfasserin aut R. A. Abdulkhakov verfasserin aut M. F. Osipenko verfasserin aut I. V. Osipova verfasserin aut D. A. Pocheptsov verfasserin aut Ye. V. Chumachek verfasserin aut O. M. Khromtsova verfasserin aut Ye. V. Kuzmicheva verfasserin aut In Российский журнал гастроэнтерологии, гепатологии, колопроктологии Gastro LLC, 2020 27(2018), 2, Seite 34-43 (DE-627)1698164203 26586673 nnns volume:27 year:2018 number:2 pages:34-43 https://doi.org/10.22416/1382-4376-2017-27-2-34-43 kostenfrei https://doaj.org/article/4131ff0071c74aa1ac7482e20794c338 kostenfrei https://www.gastro-j.ru/jour/article/view/133 kostenfrei https://doaj.org/toc/1382-4376 Journal toc kostenfrei https://doaj.org/toc/2658-6673 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 27 2018 2 34-43
spelling	10.22416/1382-4376-2017-27-2-34-43 doi (DE-627)DOAJ026246554 (DE-599)DOAJ4131ff0071c74aa1ac7482e20794c338 DE-627 ger DE-627 rakwb rus RC799-869 V. T. Ivashkin verfasserin aut Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12) 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier фосфоглив гепатопротектор неалкогольная жировая болезнь печени воспаление фиброз качество жизни Diseases of the digestive system. Gastroenterology I. G. Bakulin verfasserin aut P. O. Bogomolov verfasserin aut M. V. Matsiyevich verfasserin aut N. I. Geyvandova verfasserin aut P. V. Koroy verfasserin aut S. V. Nedogoda verfasserin aut O. A. Sablin verfasserin aut L. G. Lenskaya verfasserin aut Ye. V. Beloborodova verfasserin aut A. A. Bagretsova verfasserin aut R. A. Abdulkhakov verfasserin aut M. F. Osipenko verfasserin aut I. V. Osipova verfasserin aut D. A. Pocheptsov verfasserin aut Ye. V. Chumachek verfasserin aut O. M. Khromtsova verfasserin aut Ye. V. Kuzmicheva verfasserin aut In Российский журнал гастроэнтерологии, гепатологии, колопроктологии Gastro LLC, 2020 27(2018), 2, Seite 34-43 (DE-627)1698164203 26586673 nnns volume:27 year:2018 number:2 pages:34-43 https://doi.org/10.22416/1382-4376-2017-27-2-34-43 kostenfrei https://doaj.org/article/4131ff0071c74aa1ac7482e20794c338 kostenfrei https://www.gastro-j.ru/jour/article/view/133 kostenfrei https://doaj.org/toc/1382-4376 Journal toc kostenfrei https://doaj.org/toc/2658-6673 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 27 2018 2 34-43
allfields_unstemmed	10.22416/1382-4376-2017-27-2-34-43 doi (DE-627)DOAJ026246554 (DE-599)DOAJ4131ff0071c74aa1ac7482e20794c338 DE-627 ger DE-627 rakwb rus RC799-869 V. T. Ivashkin verfasserin aut Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12) 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier фосфоглив гепатопротектор неалкогольная жировая болезнь печени воспаление фиброз качество жизни Diseases of the digestive system. Gastroenterology I. G. Bakulin verfasserin aut P. O. Bogomolov verfasserin aut M. V. Matsiyevich verfasserin aut N. I. Geyvandova verfasserin aut P. V. Koroy verfasserin aut S. V. Nedogoda verfasserin aut O. A. Sablin verfasserin aut L. G. Lenskaya verfasserin aut Ye. V. Beloborodova verfasserin aut A. A. Bagretsova verfasserin aut R. A. Abdulkhakov verfasserin aut M. F. Osipenko verfasserin aut I. V. Osipova verfasserin aut D. A. Pocheptsov verfasserin aut Ye. V. Chumachek verfasserin aut O. M. Khromtsova verfasserin aut Ye. V. Kuzmicheva verfasserin aut In Российский журнал гастроэнтерологии, гепатологии, колопроктологии Gastro LLC, 2020 27(2018), 2, Seite 34-43 (DE-627)1698164203 26586673 nnns volume:27 year:2018 number:2 pages:34-43 https://doi.org/10.22416/1382-4376-2017-27-2-34-43 kostenfrei https://doaj.org/article/4131ff0071c74aa1ac7482e20794c338 kostenfrei https://www.gastro-j.ru/jour/article/view/133 kostenfrei https://doaj.org/toc/1382-4376 Journal toc kostenfrei https://doaj.org/toc/2658-6673 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 27 2018 2 34-43
allfieldsGer	10.22416/1382-4376-2017-27-2-34-43 doi (DE-627)DOAJ026246554 (DE-599)DOAJ4131ff0071c74aa1ac7482e20794c338 DE-627 ger DE-627 rakwb rus RC799-869 V. T. Ivashkin verfasserin aut Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12) 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier фосфоглив гепатопротектор неалкогольная жировая болезнь печени воспаление фиброз качество жизни Diseases of the digestive system. Gastroenterology I. G. Bakulin verfasserin aut P. O. Bogomolov verfasserin aut M. V. Matsiyevich verfasserin aut N. I. Geyvandova verfasserin aut P. V. Koroy verfasserin aut S. V. Nedogoda verfasserin aut O. A. Sablin verfasserin aut L. G. Lenskaya verfasserin aut Ye. V. Beloborodova verfasserin aut A. A. Bagretsova verfasserin aut R. A. Abdulkhakov verfasserin aut M. F. Osipenko verfasserin aut I. V. Osipova verfasserin aut D. A. Pocheptsov verfasserin aut Ye. V. Chumachek verfasserin aut O. M. Khromtsova verfasserin aut Ye. V. Kuzmicheva verfasserin aut In Российский журнал гастроэнтерологии, гепатологии, колопроктологии Gastro LLC, 2020 27(2018), 2, Seite 34-43 (DE-627)1698164203 26586673 nnns volume:27 year:2018 number:2 pages:34-43 https://doi.org/10.22416/1382-4376-2017-27-2-34-43 kostenfrei https://doaj.org/article/4131ff0071c74aa1ac7482e20794c338 kostenfrei https://www.gastro-j.ru/jour/article/view/133 kostenfrei https://doaj.org/toc/1382-4376 Journal toc kostenfrei https://doaj.org/toc/2658-6673 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 27 2018 2 34-43
allfieldsSound	10.22416/1382-4376-2017-27-2-34-43 doi (DE-627)DOAJ026246554 (DE-599)DOAJ4131ff0071c74aa1ac7482e20794c338 DE-627 ger DE-627 rakwb rus RC799-869 V. T. Ivashkin verfasserin aut Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12) 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier фосфоглив гепатопротектор неалкогольная жировая болезнь печени воспаление фиброз качество жизни Diseases of the digestive system. Gastroenterology I. G. Bakulin verfasserin aut P. O. Bogomolov verfasserin aut M. V. Matsiyevich verfasserin aut N. I. Geyvandova verfasserin aut P. V. Koroy verfasserin aut S. V. Nedogoda verfasserin aut O. A. Sablin verfasserin aut L. G. Lenskaya verfasserin aut Ye. V. Beloborodova verfasserin aut A. A. Bagretsova verfasserin aut R. A. Abdulkhakov verfasserin aut M. F. Osipenko verfasserin aut I. V. Osipova verfasserin aut D. A. Pocheptsov verfasserin aut Ye. V. Chumachek verfasserin aut O. M. Khromtsova verfasserin aut Ye. V. Kuzmicheva verfasserin aut In Российский журнал гастроэнтерологии, гепатологии, колопроктологии Gastro LLC, 2020 27(2018), 2, Seite 34-43 (DE-627)1698164203 26586673 nnns volume:27 year:2018 number:2 pages:34-43 https://doi.org/10.22416/1382-4376-2017-27-2-34-43 kostenfrei https://doaj.org/article/4131ff0071c74aa1ac7482e20794c338 kostenfrei https://www.gastro-j.ru/jour/article/view/133 kostenfrei https://doaj.org/toc/1382-4376 Journal toc kostenfrei https://doaj.org/toc/2658-6673 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 27 2018 2 34-43
language	Russian
source	In Российский журнал гастроэнтерологии, гепатологии, колопроктологии 27(2018), 2, Seite 34-43 volume:27 year:2018 number:2 pages:34-43
sourceStr	In Российский журнал гастроэнтерологии, гепатологии, колопроктологии 27(2018), 2, Seite 34-43 volume:27 year:2018 number:2 pages:34-43
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	фосфоглив гепатопротектор неалкогольная жировая болезнь печени воспаление фиброз качество жизни Diseases of the digestive system. Gastroenterology
isfreeaccess_bool	true
container_title	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
authorswithroles_txt_mv	V. T. Ivashkin @@aut@@ I. G. Bakulin @@aut@@ P. O. Bogomolov @@aut@@ M. V. Matsiyevich @@aut@@ N. I. Geyvandova @@aut@@ P. V. Koroy @@aut@@ S. V. Nedogoda @@aut@@ O. A. Sablin @@aut@@ L. G. Lenskaya @@aut@@ Ye. V. Beloborodova @@aut@@ A. A. Bagretsova @@aut@@ R. A. Abdulkhakov @@aut@@ M. F. Osipenko @@aut@@ I. V. Osipova @@aut@@ D. A. Pocheptsov @@aut@@ Ye. V. Chumachek @@aut@@ O. M. Khromtsova @@aut@@ Ye. V. Kuzmicheva @@aut@@
publishDateDaySort_date	2018-01-01T00:00:00Z
hierarchy_top_id	1698164203
id	DOAJ026246554
language_de	russisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ026246554</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414034717.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2018 xx \|\|\|\|\|o 00\| \|\|rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.22416/1382-4376-2017-27-2-34-43</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ026246554</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ4131ff0071c74aa1ac7482e20794c338</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC799-869</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">V. T. Ivashkin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">фосфоглив</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">гепатопротектор</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">неалкогольная жировая болезнь печени</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">воспаление</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">фиброз</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">качество жизни</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the digestive system. Gastroenterology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. G. Bakulin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">P. O. Bogomolov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. V. Matsiyevich</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">N. I. Geyvandova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">P. V. Koroy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. V. Nedogoda</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">O. A. Sablin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">L. G. Lenskaya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ye. V. Beloborodova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. A. Bagretsova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">R. A. Abdulkhakov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. F. Osipenko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. V. Osipova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. A. Pocheptsov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ye. V. Chumachek</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">O. M. Khromtsova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ye. V. Kuzmicheva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Российский журнал гастроэнтерологии, гепатологии, колопроктологии</subfield><subfield code="d">Gastro LLC, 2020</subfield><subfield code="g">27(2018), 2, Seite 34-43</subfield><subfield code="w">(DE-627)1698164203</subfield><subfield code="x">26586673</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:27</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:34-43</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.22416/1382-4376-2017-27-2-34-43</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/4131ff0071c74aa1ac7482e20794c338</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.gastro-j.ru/jour/article/view/133</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1382-4376</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2658-6673</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">27</subfield><subfield code="j">2018</subfield><subfield code="e">2</subfield><subfield code="h">34-43</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	V. T. Ivashkin
spellingShingle	V. T. Ivashkin misc RC799-869 misc фосфоглив misc гепатопротектор misc неалкогольная жировая болезнь печени misc воспаление misc фиброз misc качество жизни misc Diseases of the digestive system. Gastroenterology Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)
authorStr	V. T. Ivashkin
ppnlink_with_tag_str_mv	@@773@@(DE-627)1698164203
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut
collection	DOAJ
remote_str	true
callnumber-label	RC799-869
illustrated	Not Illustrated
issn	26586673
topic_title	RC799-869 Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12) фосфоглив гепатопротектор неалкогольная жировая болезнь печени воспаление фиброз качество жизни
topic	misc RC799-869 misc фосфоглив misc гепатопротектор misc неалкогольная жировая болезнь печени misc воспаление misc фиброз misc качество жизни misc Diseases of the digestive system. Gastroenterology
topic_unstemmed	misc RC799-869 misc фосфоглив misc гепатопротектор misc неалкогольная жировая болезнь печени misc воспаление misc фиброз misc качество жизни misc Diseases of the digestive system. Gastroenterology
topic_browse	misc RC799-869 misc фосфоглив misc гепатопротектор misc неалкогольная жировая болезнь печени misc воспаление misc фиброз misc качество жизни misc Diseases of the digestive system. Gastroenterology
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
hierarchy_parent_id	1698164203
hierarchy_top_title	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)1698164203
title	Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)
ctrlnum	(DE-627)DOAJ026246554 (DE-599)DOAJ4131ff0071c74aa1ac7482e20794c338
title_full	Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)
author_sort	V. T. Ivashkin
journal	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
journalStr	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
callnumber-first-code	R
lang_code	rus
isOA_bool	true
recordtype	marc
publishDateSort	2018
contenttype_str_mv	txt
container_start_page	34
author_browse	V. T. Ivashkin I. G. Bakulin P. O. Bogomolov M. V. Matsiyevich N. I. Geyvandova P. V. Koroy S. V. Nedogoda O. A. Sablin L. G. Lenskaya Ye. V. Beloborodova A. A. Bagretsova R. A. Abdulkhakov M. F. Osipenko I. V. Osipova D. A. Pocheptsov Ye. V. Chumachek O. M. Khromtsova Ye. V. Kuzmicheva
container_volume	27
class	RC799-869
format_se	Elektronische Aufsätze
author-letter	V. T. Ivashkin
doi_str_mv	10.22416/1382-4376-2017-27-2-34-43
author2-role	verfasserin
title_sort	efficacy and safety of glycyrrhizic acid combined to essential phospholipids (phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (iv phase) «gepard» (phg-m2/p02-12)
callnumber	RC799-869
title_auth	Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	2
title_short	Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)
url	https://doi.org/10.22416/1382-4376-2017-27-2-34-43 https://doaj.org/article/4131ff0071c74aa1ac7482e20794c338 https://www.gastro-j.ru/jour/article/view/133 https://doaj.org/toc/1382-4376 https://doaj.org/toc/2658-6673
remote_bool	true
author2	I. G. Bakulin P. O. Bogomolov M. V. Matsiyevich N. I. Geyvandova P. V. Koroy S. V. Nedogoda O. A. Sablin L. G. Lenskaya Ye. V. Beloborodova A. A. Bagretsova R. A. Abdulkhakov M. F. Osipenko I. V. Osipova D. A. Pocheptsov Ye. V. Chumachek O. M. Khromtsova Ye. V. Kuzmicheva
author2Str	I. G. Bakulin P. O. Bogomolov M. V. Matsiyevich N. I. Geyvandova P. V. Koroy S. V. Nedogoda O. A. Sablin L. G. Lenskaya Ye. V. Beloborodova A. A. Bagretsova R. A. Abdulkhakov M. F. Osipenko I. V. Osipova D. A. Pocheptsov Ye. V. Chumachek O. M. Khromtsova Ye. V. Kuzmicheva
ppnlink	1698164203
callnumber-subject	RC - Internal Medicine
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.22416/1382-4376-2017-27-2-34-43
callnumber-a	RC799-869
up_date	2024-07-03T19:53:11.590Z
_version_	1803588879351021568
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ026246554</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240414034717.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2018 xx \|\|\|\|\|o 00\| \|\|rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.22416/1382-4376-2017-27-2-34-43</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ026246554</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ4131ff0071c74aa1ac7482e20794c338</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC799-869</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">V. T. Ivashkin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">фосфоглив</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">гепатопротектор</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">неалкогольная жировая болезнь печени</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">воспаление</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">фиброз</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">качество жизни</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Diseases of the digestive system. Gastroenterology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. G. Bakulin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">P. O. Bogomolov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. V. Matsiyevich</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">N. I. Geyvandova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">P. V. Koroy</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">S. V. Nedogoda</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">O. A. Sablin</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">L. G. Lenskaya</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ye. V. Beloborodova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A. A. Bagretsova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">R. A. Abdulkhakov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">M. F. Osipenko</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">I. V. Osipova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">D. A. Pocheptsov</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ye. V. Chumachek</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">O. M. Khromtsova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ye. V. Kuzmicheva</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Российский журнал гастроэнтерологии, гепатологии, колопроктологии</subfield><subfield code="d">Gastro LLC, 2020</subfield><subfield code="g">27(2018), 2, Seite 34-43</subfield><subfield code="w">(DE-627)1698164203</subfield><subfield code="x">26586673</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:27</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:34-43</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.22416/1382-4376-2017-27-2-34-43</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/4131ff0071c74aa1ac7482e20794c338</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.gastro-j.ru/jour/article/view/133</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1382-4376</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2658-6673</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">27</subfield><subfield code="j">2018</subfield><subfield code="e">2</subfield><subfield code="h">34-43</subfield></datafield></record></collection>
score	7.4027834

Nicht das Richtige dabei?

Schreiben Sie uns!

Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?